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In Brief
Zhang et al. developed a hybrid
approach, GPCR-I-TASSER, for GPCR
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experimental mutagenesis data with ab
initio transmembrane helix assembly
simulations. The method was applied to
1,026 GPCRs in the human genome, with
successfully modeled targets containing
many pharmaceutically important
families with no previously solved
structures.
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Experimental structure determination remains diffi-
cult for G protein-coupled receptors (GPCRs). We
propose a new hybrid protocol to construct GPCR
structure models that integrates experimental muta-
genesis data with ab initio transmembrane (TM) helix
assembly simulations. The method was tested on 24
known GPCRswhere the ab initio TM-helix assembly
procedure constructed the correct fold for 20 cases.
When combined with weak homology and sparse
mutagenesis restraints, the method generated cor-
rect folds for all the tested cases with an average
Ca root-mean-square deviation 2.4 A˚ in the TM re-
gions. The new hybrid protocol was applied to model
all 1,026 GPCRs in the human genome, where 923
have a high confidence score and are expected to
have correct folds; these contain many pharmaceuti-
cally important families with no previously solved
structures, including Trace amine, Prostanoids,
Releasing hormones, Melanocortins, Vasopressin,
and Neuropeptide Y receptors. The results demon-
strate new progress on genome-wide structure
modeling of TM proteins.
INTRODUCTION
G protein-coupled receptors (GPCRs) are integral membrane
proteins that transmit chemical signals into a wide array of
different cell types. Many diseases, including those associated
with differentiation, proliferation, angiogenesis, cancer, develop-
ment, and cell survival, involve malfunctions of the receptors,
which make GPCRs one of the most widely used drug targets,
accounting for over 40% of all pharmaceuticals approved by
the US Food and Drug Administration (Eglen et al., 2007). While
knowledge of GPCR structures provides important information
for function elucidation and drug design, experimental determi-
nation of 3D structures of GPCR proteins has proved to be diffi-
cult. Significant efforts have been made on the technical
improvement of GPCR expression and crystallization, which re-1538 Structure 23, 1538–1549, August 4, 2015 ª2015 Elsevier Ltd Alsulted in successful solution of 15 human GPCRs in the last
8 years since 2007 (Jaakola et al., 2008; Rasmussen et al.,
2007). Although remarkable, these account for only a small
portion of all GPCRs in the human genome, which is estimated
to be approximately 1,000 (Takeda et al., 2002). The lack of
atomic-level protein structure information for GPCRs has
considerably hindered function annotation and structure-based
drug discovery.
Significant efforts have also beenmade recently in the compu-
tational structure modeling of GPCR proteins, with progress
witnessed on both new method development and modeling ac-
curacy (Fanelli and De Benedetti, 2011). For instance, Barth et al.
developed a structure modeling method to assemble helix-helix
packing of membrane proteins with limited constraints. In 4 of 12
proteins, themethod producedmodels of root-mean-square de-
viation (RMSD) < 4 A˚ to the X-ray structure (Barth et al., 2009).
Chen et al. presented an interesting attempt to assemble protein
transmembrane (TM) helices using distance restraints from
sparse nuclear magnetic resonance (NMR) paramagnetic relax-
ation enhancement data. Constrained with a simple geometry
pattern, TM-helix bundles up to seven helices can be correctly
constructed using one to three restraints (Chen et al., 2011).
Yang et al. combined multiple machine learning classifiers for
generating inter-TM-helix contact predictions, which have an
average accuracy of 62% in the top L/5 predictions. When incor-
porated in fragment assembly simulations, the predicted inter-
helix contact restraints increased the TM-score of the final
GPCR models by 37% (Yang et al., 2013). The contact-assisted
structure assembly approach has also been exploited by several
recent modeling studies for GPCR and other TM proteins (Hopf
et al., 2012; Nugent and Jones, 2012).
Despite these advances, the majority of computational ap-
proaches to GPCR modeling rely on the detection of homolo-
gous templates (Fanelli and De Benedetti, 2011; Zhang et al.,
2006). It is well known that pairwise sequence identity between
GPCR families is low, and close homologous templates are not
available for most of the unknown GPCR families (Archer et al.,
2003). Despite the limited availability of global X-ray structures,
numerous mutagenesis experiments have been performed on
GPCRs to identify the critical residues and motifs, which contain
spatial information for improving the modeling accuracy of
GPCR structures. For example, the coupled activation and deac-
tivation of residues in mutagenesis experiments usually indicatel rights reserved
Figure 1. Flowchart of the GPCR-I-TASSER Protocol for GPCR
Structure Modelingthat the residues are spatially adjacent because they are binding
to common ligands (Shi and Javitch, 2002). Furthermore, the
orientation of mutated functional residues is usually toward the
inside core of the seven-helix bundle due to the conservation
of inter-helix contacts (Schushan et al., 2010). Thus, specific
contacts and distance maps and residue orientations can be
derived from the mutagenesis experimental data and converted
into 3D restraints to guide the GPCR structure modeling simula-
tions. This is particularly helpful for the modeling of structurally
variable regions that cannot be directly transferred by homology
inference.
In this work, we aim to develop a new hybrid structure assem-
bly algorithm, GPCR-I-TASSER, by extending the iterative
threading assembly method (I-TASSER). The major advantages
of GPCR-I-TASSER over existing homology-basedmethods are:
(1) A new GPCR-specific database, GPCR-RD (Zhang and
Zhang, 2010a) containing experimental contact and helix
orientation data from the literature and database mining,
is exploited to improve the structural assembly accuracy;
(2) When homology templates are unavailable, a new ab initio
folding method is introduced for assembling the TM-helix
bundle topology from scratch;
(3) A set of new GPCR- and TM-specific energy terms is
developed and incorporated into the I-TASSER force field
to improve the structure assembly and refinement of both
ab initio and threading template models. The major focus
of this work is to construct reliable models for the GPCRs
that lack close homologous templates.
To examine the efficiency, we first test GPCR-I-TASSER on all
known GPCRs in the PDB and report the blind test results from
the community-wide GPCR Dock experiments. It was found
that the new pipeline can significantly improve the modeling ac-
curacy of template structure identified from threading. ForStructure 23, 1538GPCRs without homologous templates, the ab initio folding pro-
cess can construct an approximately correct fold for all recep-
tors with assistance from sparse mutagenesis data. The algo-
rithm was finally applied to the modeling of all putative GPCRs
in the human genome. The comparison with new mutagenesis
data and confidence scoring system showed that nearly 90%
of targets are expected to have correct folds, including many
GPCRs from the families that have no previously solved experi-
mental structures.
RESULTS
GPCR-I-TASSER, as depicted in Figure 1, has three steps con-
sisting of template identification (or ab initio TM-helix construc-
tion) and experimental restraint collection, Monte Carlo fragment
assembly simulation, and atomic-level structural refinement (see
Experimental Procedures and Supplemental Experimental Pro-
cedure, for details).
Benchmark Test on 24 Solved GPCRs
To benchmark GPCR-I-TASSER, we collected a set of test struc-
tures containing all 24 GPCRs solved so far in the PDB. Since
there are multiple entries solved for single GPCRs, we used
CD-HIT (Fu et al., 2012) to remove the redundancy of these en-
tries, which retains the entries having the longest structural
coverage for each GPCR family. Table S1 lists the name and or-
ganism of the test GPCRs. Since many GPCRs were solved with
fused external domains for facilitating crystal nucleation and
structure determination, these domains have been excluded in
our structure modeling. Table S2 lists the GPCR domains after
manual trimming and the TM-helix annotations taken either
from the original literature source or from manual inspection of
the PDB structure. An updated list of all GPCRs solved in the
PDB can be found at http://zhanglab.ccmb.med.umich.edu/
GPCR-EXP/.
Distant Homology Modeling
We first tested GPCR-I-TASSER by excluding all homology tem-
plates that have a sequence identity to target > 30% or are
detectable by PSI-BLAST with an E value < 0.05. Despite the
relatively stringent filters, many GPCR targets still have some
analogous templates, which can be detected by LOMETS (Wu
and Zhang, 2007). The threading search generated templates
with an average RMSD = 5.74 (or 3.7) A˚ to the entire chain (or
the TM-helix domains) of the native. The average TM-score of
the templates is 0.675 (or 0.755). Here and afterward, the
RMSD is calculated on Ca atoms only. TM-score is a sequence
length-independent metric for measuring structure similarity
with a range (0, 1). A TM-score > 0.5 generally corresponds to
similar structures in the same SCOP/CATH fold family (Xu and
Zhang, 2010). Such a high TM-score of the template detection
by LOMETS probably reflects the focus of the experimental
efforts that have beenmade on a set of similar GPCRs; therefore,
templates can be inferred easily for the benchmark targets from
other solved homologous GPCR structures. We have conducted
a simple exercise by counting the homologous templates
defined by the LOMETS alignments. The average number of ho-
mologous templates with a LOMETS Z-score above the confi-
dence Z-score cutoff is 3.9 in this benchmark set, which is
2.4 timeshigher than theaverage for all other humanGPCRs (1.6).–1549, August 4, 2015 ª2015 Elsevier Ltd All rights reserved 1539
Table 1. Summary of the Structure Modeling on 24 Benchmark
GPCRs
Template Filter Methods RMSD (A˚) TM-score
Excluding all
homologous
templates
threadinga 5.74 (3.70) 0.675 (0.755)
MODELLERb 8.07 (3.85) 0.694 (0.764)
GPCR-I-TASSER (ali)c 4.22 (2.32)
GPCR-I-TASSERd 5.09 (2.40) 0.806 (0.868)
Excluding all
homologous and
membrane protein
templates
threadinga 12.46 (10.25) 0.096 (0.102)
MODELLERb 21.74 (11.42) 0.142 (0.149)
ab initio folding (1)e 11.39 (8.96) 0.389 (0.389)
ab initio folding (B)f 10.81 (8.31) 0.412 (0.419)
GPCR-I-TASSER (1)e 8.57 (6.37) 0.517 (0.517)
GPCR-I-TASSER (B)f 8.35 (6.25) 0.524 (0.526)
Values in parentheses are for the transmembrane region (see also Tables
S1–S4 in Supplemental Information).
aBest template by LOMETS.
bMODELLER model based on the best template.
cRMSD of the first model in the threading-aligned region.
dRMSD and TM-score of the first model in entire chain.
eFirst model.
fThe best in top five models.Despite the good quality of the threading alignments, GPCR-I-
TASSER repacked the structure of the TM helices and drew the
threading templates considerably closer to the native.
Compared with the experimental structure, the first GPCR-I-
TASSER models have the average RMSD reduced from 5.74 A˚
to 4.22 A˚ by 1.52 A˚ in the same threading alignment regions.
The TM score increased from 0.675 to 0.806 by 19.4%. A
detailed list of the threading templates and GPCR-I-TASSER
models is given in Table S3, where values in parentheses are
RMSD and TM-score data in the TM regions, and values after
‘/’ are RMSD of the GPCR-I-TASSER models in the threading-
aligned regions. A summary of the results is presented in Table 1.
In Table S3, we also present the results by the widely used
comparative modeling tool, MODELLER (Sali and Blundell,
1993), based on the best LOMETS templates. SinceMODELLER
is designed to construct models by optimally satisfying spatial
restraints from templates, there is not much improvement of
the final models over templates. Compared with LOMETS tem-
plates, the average RMSD of the MODELLER models increases
from 5.74 to 8.07 A˚ and TM-score increases from 0.675 to 0.694
in the TM region; thesemoderate RMSD/TM-score increases are
probably mainly a result of the length increase in theMODELLER
modeling.
Goddard and colleagues developed a program, MembStruk,
for GPCR structure prediction (Vaidehi et al., 2002). At the time
of the MembStruk modeling, only one GPCR with experimental
structure was available (i.e., bovine rhodopsin). MembStruk
built a model with an RMSD = 3.1 A˚ in the TM-helix region
and an RMSD = 8.3 A˚ in full-length regions of bovine
rhodopsin. As the models generated by MembStruk are not
available publicly, we compare GPCR-I-TASSER with Mem-
bStruk on this GPCR only. As shown in Table S3, the RMSD
of the GPCR-I-TASSER model for bovine rhodopsin (2hpyB)
is 1.35/5.25 A˚ in the TM-helix/all regions, which is 1.75/
3.05 A˚ lower than the MembStruk model. However, we note1540 Structure 23, 1538–1549, August 4, 2015 ª2015 Elsevier Ltd Althat this comparison might not be entirely fair because there
are now more GPCR structures that can serve as templates.
We have re-run GPCR-I-TASSER by excluding all GPCR tem-
plates (but keeping other membrane structures) in the template
library, which resulted in the first predicted model of bovine
rhodopsin with 1.82/6.31 A˚ in the TM-helix/all regions; these
RMSD values are slightly higher than the data in Table S3
but still considerably lower than that of the MembStruck
results.
In Figure 2A, we present two examples from human opioid re-
ceptor (PDB: 4ej4A1) (Granier et al., 2012) and human serotonin
receptor (PDB: 4iarA1) (Wang et al., 2013), which represent two
targets with themost significant structure refinements, where the
threading templates have a TM-score = 0.644 and 0.645 but
GPCR-I-TASSER refined the models to TM-score = 0.894 and
0.884, respectively. The major improvement occurs at the TM-
helix regions, where the RMSD was reduced from 4.66 and
4.67 A˚ to 1.44 and 1.7 A˚, respectively. This improvement is
mainly attributed to the new GPCR-specific helical packing po-
tential and the atomic-level fragment-guided molecule dynamic
(FG-MD) refinements.
Compared with the TM-helix regions, the modeling of loop
structure is more challenging since these regions are less
conserved and the threading programs often have alignment
gaps. In the 24 proteins, there are on average 7.9% of residues
without threading alignments, which are mainly located on the
loops/tails. The GPCR-I-TASSER pipeline constructs models
for these regions by a lattice-based, ab initio structure assembly
procedure extended from the I-TASSERprotocol, which resulted
in models with an average RMSD = 5.37 A˚ for the six intra- and
extracellular loops. For the functionally important second extra-
cellular loop (EL2) that is often involved in ligand recognition and
receptor activation, the average RMSD is 3.85 A˚, with an average
length of 20.4 amino acids in this test.
It should be mentioned that the quality of template-based
structure modeling is sensitive to the level of homologous tem-
plate filtering. For instance, if we only filtered out the templates
of sequence identity > 30% (i.e., dropping off the PSI-BLAST
E-value filter) as done in many previous benchmark experiments
of structure prediction (Simons et al., 1999; Zhang and Skolnick,
2004a), the TM-score and RMSD of the threading templates will
increase to 0.756 and 4.65 A˚, respectively, while the quality of the
GPCR-I-TASSER models will be improved accordingly with an
average TM-score = 0.912 and RMSD = 3.21 A˚ (or 1.57 A˚ in
the TM-helix and 3.35 A˚ in the loop regions).
Ab Initio GPCR Folding
Most GPCRs in the human genome are not closely homologous
to the solvedGPCRs in the PDB. To examine the ability of GPCR-
I-TASSER in ab initio structure assembly, we exploited a second
level of template filtering, i.e., to regenerate the models by
excluding all GPCR and membrane proteins from our template
library.
Since all correct templates have been excluded, it is expected
that the templates detected by threading will now have a
completely different topology from the native structures. The
average TM-score of the templates with the highest Z-score is
0.096, which is well below the average of random structure pairs
(0.17) (Xu and Zhang, 2010; Zhang and Skolnick, 2004b). When
we applied MODELLER (Sali and Blundell, 1993) to thesel rights reserved
Figure 2. Illustrative Examples of GPCR
Structural Modeling, with Blue and Red
Representing Model and Experimental
Structure, Respectively
(A) Template-based modeling on human opioid
(PDB: 4ej4A1) (Granier et al., 2012) and serotonin
(PDB: 4iarA1) (Wang et al., 2013) receptors with
close homologous templates detectable by PSI-
BLAST or sequence identity > 30% excluded. Left
to right columns are the LOMETS templates and
GPCR-I-TASSER models overlaid on the native in
the whole chain and TM-helix regions, respec-
tively.
(B) Ab initio modeling on human adenosine A2a
receptor (PDB: 3emlA1) (Jaakola et al., 2008) with
all homologous and membrane templates
excluded. Left to right columns are the models
built by MODELLER, ab initio assembly, and
GPCR-I-TASSER models overlaid with TM regions
of the native structure, respectively.templates for full-length model construction using the default
setting, a similar set of random models were obtained with an
average TM-score = 0.142 and RMSD = 21.74 A˚ (Table 1). This
is expected again because MODELLER was designed to
construct structure models by satisfying spatial restraints from
templates, an approach best suitable to the targets with close
homologous templates.
To build a de novo TM-helix bundle topology, GPCR-I-
TASSER first performs a rapid ab initio Monte Carlo assembly
simulation, which starts from ideal helix bundles (Figure 3), with
the conformational search guided mainly by the generic atomic
contact and membrane transfer potentials (Equations S2 and
S3 in Supplemental Experimental Procedure). The structural de-
coys were clustered by SPICKER (Zhang and Skolnick, 2004c),
which resulted in the first ab initio models with an average TM-
score = 0.389 and RMSD = 11.39 A˚ (Table 1). In nine cases,
the models have a TM-score > 0.4, which indicates an approxi-
mately correct topology of the TM-helix assembly (Xu and
Zhang, 2010). If we consider the best in the top five models,
this number increases to 17 (see Table S4).
Starting from the ab initio TM-helix models and the low-reso-
lution threading template alignments, GPCR-I-TASSER MonteStructure 23, 1538–1549, August 4, 2015 ªCarlo simulations were conducted to re-
assemble the TM helices that have the
relative orientations restricted by the
loop structures. Meanwhile, 294 spatial
restraints were extracted from the
GPCR-RD database for the 24 test
GPCRs. On average, seven residue-resi-
due contact restraints and five helix orien-
tation restraints per target were used to
constrain the simulations. This procedure
generated full-length models with an
average TM-score = 0.517, which is
32% higher than that of the models
created by ab initio folding. All the targets
have a TM-score > 0.4, and 20 of 24 tar-
gets have a TM-score > 0.5 (Table S4).To test the effect of the mutagenesis restraints, we also ran
a version of GPCR-I-TASSER without restraints from GPCR-
RD. The average TM-score of the final model decreased by
3.9%. The TM-score reduction in this set of models was
found considerably larger than that of the template-based
models from the last section (1.4%); this is understandable
because the mutagenesis restraints are implemented using
a relatively large distance cutoff (i.e. dij < 10 A˚ in Equation S9)
or with helix orientation adjustment (Equation S10), which
should have a stronger effect on refining models with low
resolution.
To illustrate the procedure of ab initio folding, in Figure 2B we
show the structural superposition of the predictedmodels for the
adenosine A2a receptor over the experimental structure (PDB:
3emlA1) (Jaakola et al., 2008) from the three modeling steps.
The LOMETS programs hit incorrect templates, which resulted
in the MODELLER model with a different topology (TM-score =
0.188). The ab initio folding procedure rearranged artificial heli-
ces and constructed a TM-helix bundle with approximately
correct topology (TM-score = 0.496). The GPCR-I-TASSER
refinement simulations improved the structural model to a TM-
score = 0.581.2015 Elsevier Ltd All rights reserved 1541
Figure 3. Illustrations for Ab Initio TM-Helix
Folding
(A) Initial conformation and variable definitions.
(B) Monte Carlo movements in the ab initio TM-
helix folding.The data for the 24 benchmark proteins, including template
alignments, ab initio folding, and GPCR-I-TASSER models, are
downloadable at http://zhanglab.ccmb.med.umich.edu/GPCR-
I-TASSER/benchmark.
Blind Test in the GPCR Dock Experiment
As a blind test of GPCR-I-TASSER, we participated (as UMich/
0460) in the community-wide GPCR Structure-based Homology
Modeling and Docking Assessment 2010 (or GPCR Dock 2010),
organized by Kufareva et al. (2011). In the experiment, the orga-
nizers requested structure predictions for three GPCR-ligand
complexes that were solved by Stevens and coworkers (Chien
et al., 2010; Wu et al., 2010): the human CXCR4 chemokine re-
ceptor bound either to the small molecule antagonist IT1t or to
the peptide antagonist CVX15, and the human dopamine D3 re-
ceptor with eticlopride. The predictions were blind, as the target
structures were not released until the predictions were
completed.
In Figure 4, we show the GPCR models built by the GPCR-I-
TASSER pipeline in GPCR Dock 2010, where the GPCR-RD
restraint data were not exploited. First, LOMETS threading iden-
tified B1AR and B2AR as the templates for the CXCR4 and D3
receptors, respectively, which have a TM-score of 0.695 and
0.627, respectively. The RMSDs of the templates in the thread-
ing-aligned region of the TM helices are 3.06 A˚ and 1.61 A˚,
respectively. After GPCR-I-TASSER reassembly, the final
models have a TM-score = 0.771, 0.768, 0.917 for CXCR4/
IT1t, CXCR4/CVX15, and D3/eticlopride, respectively, which
are 11%, 11%, and 46% higher than the initial templates. In
the same threading-aligned TM region, RMSDs of the final
models are 2.08 A˚, 2.58 A˚, and 1.26 A˚, respectively, which are
0.98 A˚, 0.48 A˚, and 0.35 A˚ lower than the initial templates. These
results confirm that GPCR-I-TASSER has the ability to draw
threading templates considerably closer to the native structure.
The ligand-boundGPCRmodelsweregeneratedbyBSP-SLIM
(Lee and Zhang, 2012), which first identified the ligand-binding
pocket positions on the receptor protein by structurally aligning1542 Structure 23, 1538–1549, August 4, 2015 ª2015 Elsevier Ltd All rights reservedthe receptor models to known complex
structures in the PDB using TM-align
(Zhang and Skolnick, 2005). The ligand-
docking models were then generated
from a conformational searchwith ligands
constrained in the predicted binding
pocket. The ligand-GPCR binding energy
in BSP-SLIM consists of hydrogen-
bonding, statistical contact potential, sol-
vation, and van der Waals interactions.
The RMSDs of the final ligand models by
BSP-SLIM are 9.61, 7.35, and 3.51 A˚, for
CXCR4/IT1t, CXCR4/CVX15, and D3/eti-
clopride, respectively (Figure 4).Table S5 lists the top ten groups in GPCRDock 2010 based on
the cumulative Z-scores of the receptor and ligand models for all
three targets. Among the 35 participant groups, the UMich-
Zhang/0460 groups using GPCR-I-TASSER had the highest
Z-score in the receptor models and the second highest in the
ligand-docking positions, which resulted in the highest total
Z-score of receptor and ligandmodels, according to the analysis
by Kufareva et al. (2011). The most noticeable success is on the
distant homologous target CXCR4/CVX15, whereby the asses-
sors commented in the assessment article that ‘‘Modeling the
CXCR4/CVX15 peptide complex represented the biggest chal-
lenge of GPCR Dock 2010. The top model of this complex (#5
byUMich-Zhang) has theZ-score of 2.4, thus far exceeding other
models in accuracy’’ (Kufareva et al., 2011). For the twoother less
challenging targets (CXCR4/IT1t and D3/eticlopride), however,
although the TM-backbone RMSD of the receptor models is
ranked at the top for both targets, the accuracy of the functionally
important EL2 and the ligand-docking score are considerably
worse than the top performing groups (http://ablab.ucsd.edu/
GPCRDock2010/), highlighting the need to improve EL2
modeling and BSP-SLIM docking.
We note that the GPCR Dock experiment aims to benchmark
the modeling of GPCR-ligand complexes with an emphasis on
the ligand-docking technique. The receptor structure submitted
by the other groupsmay not reflect the best receptor models due
to the consideration of ligand-docking interactions. Neverthe-
less, the data provide a partial but independent assessment of
GPCR-I-TASSER on the GPCR structure modeling compared
with other state-of-the-art approaches.
Structure Modeling of 1,026 GPCRs in the Human
Genome
GPCR-I-TASSER Modeling
A total of 1,063 distinct GPCR sequences in the human genome
were collected by scanning the databases GPCR-DB (http://
www.gpcr.org/7tm/data/) and UniProt (http://www.uniprot.org/
docs/7tmrlist). Since errors often exist in automated data
Figure 4. Ligand-Receptor Docking Models Generated by GPCR-I-
TASSER and BSP-SLIM in GPCR Dock 2010
Blue and red represent predicted models and experimental structures,
respectively. Left to right columns are models for CXCR4 chemokine receptor
with IT1t (PDB: 3oe6) (Wu et al., 2010), CXCR receptor with CVX15 (PDB: 3oe0)
(Wu et al., 2010), and dopamine D3 with eticlopride (PDB: 3pbl) (Chien et al.,
2010), respectively. TM-score listed is for the whole-chainmodel and RMSDTM
listed is the deviation of the model in the TM region relative to the native
(Kufareva et al., 2011).collection, we used a semi-manual procedure to examine these
GPCR sequences: First, we generated TM-helix prediction by
three TM prediction programs from HMMTOP (Tusnady and
Simon, 1998), MEMSAT (Jones et al., 1994), and TMHMM (Krogh
et al., 2001). If the number of TM helices predicted by any of the
programs is less than seven or the number of overlapped resi-
dues between the TM regions by the three programs is less
than five, we manually examined these sequences (about 400)
by checking the UniProt annotation on the TM helices. In case
there is no UniProt annotation, we used the GPCR-I-TASSER
structuremodels to extract the TM helices.With this manual veri-
fication, we identified 37 non-GPCR sequences where most of
them are extracellular domains attached to the receptor but
mis-classified as GPCRs. 1,026 validated GPCR sequences
were retained for GPCR-I-TASSER modeling.
The GPCR sequences were first threaded through the PDB li-
brary using LOMETS (Wu and Zhang, 2007). In 862 cases, at
least one of the programs used by LOMETS identified template
structures with a significant Z-score above the confidence cutoff
of the corresponding program. For the rest of proteins, we con-
structed the initial TM-helix bundle conformations using the ab
initio folding procedure.
In the next step, we collected the sparse experimental data
from GPCR-RD (Zhang and Zhang, 2010a), a manually curated
database containing multiple GPCR data on site-directed muta-
genesis, electron microscopy, neutron diffraction, Fourier trans-
form infrared spectroscopy, and disulfide bridge. The experi-
mentally identified disulfide bridges and functionally important
residues (binding to a particular ligand) indicate that these resi-
dues should be close to each other to perform their functions.
So we applied contact restraints to these residue pairs as
described in Equation S9. Besides, the majority of the function-
ally related point mutations should face to the inside core of the
TM-helix bundle (Schushan et al., 2010), which are used to guide
the packing of helix orientations as described in Equation S10.Structure 23, 1538These resulted in 3,425 contacts and 1,401 orientation restraints
for the 1,026 human GPCRs. These restraints, together with the
threading alignments and ab initio TM-helix models, were used
to guide the GPCR-I-TASSER assembly simulations. The atomic
details were finally refined by the FG-MD simulation program
(Zhang et al., 2011).
For the sequences containing extra domains, which are de-
tected by TheaDom (Xue et al., 2013), models are created for
each domain individually using GPCR-I-TASSER (for TM
domain) or I-TASSER (for globular domain). The full-length
GPCR models are then constructed by assembling the domain
structures as described in the Supplemental Experimental Pro-
cedure. This domain parsing and assembly procedure can
improve the confidence score and modeling accuracy of the in-
dividual domains as demonstrated in previous benchmark tests
(Zhang, 2014). A multiple-domain example from Q6ZMI9, which
contains a TM and a globular domain, is presented in Figure 5A,
where the domain parsing and assembly procedure increased
the C-score (defined below) from 1.79 of the full-chain
GPCR-I-TASSER model to 1.11 for the globular domain and
1.32 for the GPCR domain, respectively.
All themodels for the1,026humanGPCRsbyGPCR-I-TASSER,
together with the template alignment, local and global confidence
scoring annotations, and the secondary structure and solvation
predictions, are deposited in the GPCR-HGmod database
(http://zhanglab.ccmb.med.umich.edu/GPCR-HGmod/). Due to
the sensitivity of the model quality to the templates in the PDB,
the model prediction for all human GPCRs will be updated every
12months (the oldmodels will be archived in the online database
for tracking progress).
Global Confidence Score Analyses
In Figure 6, we present a histogram distribution of the confidence
scores (C-score) of the GPCR-I-TASSER models. Here, C-score
is defined as the product of the normalized Z-score from
LOMETS threading and the cluster density from SPICKER, i.e.
C-score= ln
 
M=Mtot
hRMSDi 
1
9
X9
i =1
Zi
Zcuti
!
(Equation 1)
where M/Mtot is the normalized multiplicity of the structure de-
coys in the cluster, hRMSDi is the average RMSD of the decoys
to the cluster centroid, Zi is the highest Z-score of the template
detected by the ith threading program in LOMETS, and Zcuti is
the corresponding Z-score cutoff for distinguishing between
good and bad template alignments (see Supplemental Experi-
mental Procedure). The C-score has a strong correlation coeffi-
cient (0.91) to the actual TM-score of the predicted models
based on large-scale benchmark tests (Zhang, 2008).
From the histogram of TM-score data obtained from the
benchmark study, we roughly estimated the number of GPCRs
expected to have a TM score > 0.5, which indicates a similar
fold to the target, i.e.,
PMbin
m=1Nmrm whereMbin = 15 is the number
of bins split in the C-score space, Nm is the number of GPCR-I-
TASSERmodels in themth C-score bin, and rm is the folding rate
for the GPCR-I-TASSER/I-TASSER models in themth bin based
on large-scale benchmark tests on 1,107 known proteins,
including the 24 GPCR proteins from the PDB library. We found
that there are 923 cases out of the 1,026 GPCRs that should
have the highest ranked model with a correct topology–1549, August 4, 2015 ª2015 Elsevier Ltd All rights reserved 1543
Figure 5. Illustration Examples of the
Multi-Domain Assembly and TM Structure
Packing
(A) Multi-domain modeling for UniProt: Q6ZMI9.
The N-terminal domain was excised from the
UniProt sequence following the ThreaDom linker
prediction. This globular domain and the core TM
domain were modeled separately by I-TASSER
and GPCR-I-TASSER; the final model was
assembled from the structure of two domains with
the domain orientation decided by the full-chain
GPCR-I-TASSER model. An FG-MD refinement
was conducted on the full-chain models to elimi-
nate possible steric clashes.
(B) GPCR-I-TASSER models for UniProt:
Q8NGQ3. The left panel shows the model gener-
ated when the membrane repulsive energy was
turned off, where the N-terminal tail entered into
the transmembrane region. The right panel shows
that the tails were moved out of the membrane
when the membrane repulsive energy in Equa-
tion S4 was included.(TM-score >0.5). This number is similar to the direct counting of
GPCRs with a C-score > 1.5, which is a cutoff that approxi-
mately corresponds to the correct models in the benchmark
data (Zhang, 2008). In addition, all the models predicted by
GPCR-I-TASSER have the typical seven TM-helix bundle topol-
ogy because of the ab initio folding algorithm and the GPCR-RD
experimental restraints, although a number of GPCRs (200) did
not have any TM templates detected by the threading search.
Here, we note that the C-score histogram in Figure 6 was calcu-
lated based on the whole-chain GPCR sequences, which may
contain multiple domains. If we count only for the TM domains,
the number of folded cases should be slightly higher since the
domain parsing and assembly procedure can increase the
C-score and modeling accuracy of individual domains, as illus-
trated in Figure 5.
The 923 high C-score GPCRs cover 53 of the 54 families in the
human genome; the only missed family is Family 3 metabotropic
glutamate and calcium receptors, none of the four members of
which (Q8NFJ5, Q9NQ84, Q9NZD1, Q9NZH0) has a confident
prediction from GPCR-I-TASSER. Since the experimentally
solvedGPCRs cover only 16 families (Table S1), such a high fam-
ily coverage partly demonstrates the ability of GPCR-I-TASSER
to model distant homology proteins across different families.
In Table S6, we list the top 20 families that have the highest
number of GPCRs with a C-score > 1.5. As expected, for the
families that have some members with experimentally solved
structures, all the GPCRs have high C-score models generated
due to the easily detected homologous templates. While most
of the high C-score GPCRs are from the Odorant/olfactory and
gustatory family, GPCR-I-TASSER also generated models of
high C-scores for many families that have no experimentally
solved members but are pharmaceutically important drug tar-
gets, including Trace amine-associated (brain monoamine regu-
lation; Panas et al., 2012), Prostanoids (initiating cancer and
inflammation pathways; Breyer et al., 2001), Releasing hor-1544 Structure 23, 1538–1549, August 4, 2015 ª2015 Elsevier Ltd Almones (progression of cancers; Harrison et al., 2004), Melano-
cortins (familial glucocorticoid deficiency type 1; Vassart and
Costagliola, 2011), Vasopressin (nephrogenic diabetes insipi-
dus; Vassart and Costagliola, 2011), and Neuropeptide Y (anxi-
ety and pain; Brothers and Wahlestedt, 2010) receptors.
Residue-Level Local Quality and B-Factor Estimation
While C-score is designed to assess the confidence of the global
topology, the accuracy of local structures also needs to be as-
sessed because it is important for function annotation and virtual
screening. We developed a procedure, called ResQ, to estimate
the residue-level quality of the GPCR models based on large-
scale support vector regression training of decoy 3D models.
The training features of ResQ include (1) structure variation of
GPCR-I-TASSER assembly simulation; (2) consistency between
model and sequence-based feature prediction; (3) threading
alignment coverage; (4) B-factor of threading templates; (5)
sequence profile (see Supplemental Experimental Procedure).
A benchmark test on 635 non-redundant proteins showed that
the residue-level accuracy can be estimated with an average er-
ror 2.15 A˚ and the estimated B-factor has a Pearsons correla-
tion coefficient 0.58 with the X-ray crystallography data (Yang
et al., 2015).
The local structure quality estimates on the GPCR-I-TASSER
models showed that 89% of the 365,343 residues in the 1,026
GPCRs are correctly modeled if we consider a distance toler-
ance < 2 A˚. The majority of the incorrectly predicted residues
are located in the loop or tail regions, which have an average
local error 3.62 A˚ higher than the residues in the conserved TM
helices. Interestingly, the EL2 loops have an average error
2.56 A˚ lower than other loop and tail residues, which is probably
due to the detection of better structure profiles for these loops.
While these local structure analysis data highlighted uncer-
tainties in the unaligned regions, the functionally important EL2
loops were modeled with higher certainty than the other un-
aligned non-TM-helix regions.l rights reserved
Figure 6. C-score Distribution of GPCR-I-TASSER Models for 1,026
GPCRs in the Human Genome
(Inset) Percentage of the cumulative counts alongwith theC-score distribution.In Figure 7, we present an example of the estimated local
structure accuracy and B-factor profiles, in control with the
X-ray crystallography data from the histamine H1 receptor
(PDB: 3rzeA1) (Shimamura et al., 2011). The distance errors
are mainly located in the unaligned loop and tail regions, which
are highly consistent with the ResQ estimation. These profiles
are provided for each of the GPCR-I-TASSER models in the
GPCR-HGmod database.
Sequence and Structure Networks of Human GPCRs
Given the sequence and structural models generated, we pre-
sent in Figure 8 a 2D view of the sequence and structure distribu-
tions of all 1,026GPCRs in human prepared using Cytoscape 2.8
(Cline et al., 2007). The sequence similarity matrix is measured
by pairwise sequence identity calculated by NW-align (http://
zhanglab.ccmb.med.umich.edu/NW-align/), where a cutoff of
50% is used to ensure that the connected nodes have conserved
functionality. There are 151 GPCR clusters or orphans with an
average number of neighbors = 8.9, and the average number
of neighbors of non-orphan clusters is 10.9.
In the structure space, the distance matrix is measured by the
pairwise TM-score of the GPCR-I-TASSERmodels, where a cut-Structure 23, 1538off of TM-score > 0.95 is used for node connections to distin-
guish subtle structural similarity. The total number of the clusters
or orphans is 171 in structure space, similar to the number in
sequence space. However, the average number of neighbors
for the non-orphan clusters is 41.2, which is much higher than
that in the sequence space, despite the stringent TM-score cut-
off. These data suggest that human GPCRs are much more
converged in structure space than in sequence space. We
have re-examined the data using more permissive sequence
identity cutoffs in the 30%–50% range or TM-score cutoffs in
0.6–0.95 but the clustering data did not qualitatively change.
The high degree of conservation in structure space is partly
because GPCR structures are largely constrained by the seven
TM-helix bundle topology, despite considerable variations exist-
ing in the relative location and orientation of helices and arrange-
ment of loops. There are, however, a few big families, such as ol-
factory receptors, which have a highly similar structure but with
very diverse pairwise sequence identity. The biggest cluster in
structure space includes 711 members, which all belong to the
class A rhodopsin-like receptors and have a sequence identity
as low as 17%. Thus, high-resolution structure modeling should
serve as a useful complement to sequence-based analysis for
GPCR function annotation.
Cross-Validation of GPCR-I-TASSER Models with
Experimental Mutagenesis Data
Although the number of experimental 3D structures for GPCRs is
low, numerous experiments have been performed on GPCRs to
identify the critical residues and motifs from site-directed muta-
genesis, solid-state NMR, and neutron diffraction data. Many of
these data have been collected in the GPCR-RD database
(Zhang and Zhang, 2010a) and converted into the 3D spatial re-
straints to guide the GPCR-I-TASSER structure modeling. To
validate the GPCR-I-TASSER structure models, we compared
the predictions with recently collected mutagenesis data that
had not yet been incorporated into the GPCR-RD at the time of
modeling.
To test the high-confidence models, we collected 58 GPCR-I-
TASSER models that have a C-score > 1.0 and at least one con-
tact residue pair from the new mutagenesis experiments.
Excluding the N- and C-terminal tails, we found that all the first
models by GPCR-I-TASSER have their residue contacts consis-
tent with the mutagenesis data, i.e., with Ca distance < 10 A˚ forFigure 7. An Illustration of ResQ-Based
Local Structure Quality Estimation on the
Human Histamine H1 Receptor
(A) Overlay of the GPCR-I-TASSER model (blue)
and the X-ray structure; (B) secondary structure
assignment by STRIDE; (C) predicted and actual
distance deviations of the model from the X-ray
structure; (D) predicted and actual B-factor pro-
files of the target.
PDB: 3rzeA1 (Shimamura et al., 2011).
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Figure 8. GPCR Sequence Network and
Structure Network in Human Genome
GPCR sequence network (A) and structure
network (B) in human genome. The nodes with
more connections are shown in red and those with
fewer connections in green. The plot is generated
using Cytoscape 2.8 (Cline et al., 2007).contact restraints or Eorientation < 0 from Equation S10 for the
orientation restraints. In Figure 9, we present a set of randomly
selected examples from the high-confidence GPCR-I-TASSER
models where the key functional residues are highlighted.
Figure 9A shows the GPCR-I-TASSER model for the formyl
peptide receptors, which respond to chemokines and chemoat-
tractants found on the surface of phagocytes. There are three
residue pairs (D106-R205, A68-N44, and N44-N66) and two
functionally related residues (D71 and R123) which are sup-
posed to be in contact with each other based on the mutation
and ligand-binding analysis experiments (Lala et al., 1993; Mills
et al., 2000; Prossnitz et al., 1999). These residue pairs are all
in contact in our formyl peptide receptor model with distances <
10 A˚ (Figure 9A).
Figure 9B shows a second example from the C5a anaphyla-
toxin chemotactic receptors that mediate cell activation and re-
ceptor desensitization. One disulfide bond (C293-C86), two res-
idue pairs (P257-C285 and G210-M120), and two functionally
important residues (P170 and Q259) should be in contact ac-
cording to the experimental data (Baranski et al., 1999; Giannini
et al., 1995; Kolakowski et al., 1995; Raffetseder et al., 1996),
which is also consistent with the GPCR-I-TASSER models.
Figures 9C and 9D are two other examples from the galanin re-
ceptor and the type 1 angiotensin II receptor, respectively. In Fig-
ure 9C, one contact pair (H263-R285) and four functional resi-
dues (H263, H267, H285, and H289) from the mutagenesis
experiments (Berthold et al., 1997; Kask et al., 1996) are all
consistent with the GPCR-I-TASSER model. In Figure 9D, six
function-related residues (N111, A104, S115, W153, T260, and
N295) form a well-shaped binding pocket in the GPCR-I-
TASSERmodel, which were identified in the mutagenesis exper-
iments as critical binding residues with the non-peptide ligands
(Perlman et al., 1995, 1997; Schambye et al., 1994).
Conclusions
Progress in experimental GPCR structure determination has
been slow due to difficulties in acquiring high-resolution experi-
mental data. Computational approaches can also produce high-
resolution models, but so far they have been limited to cases
where a homologous template is available. To address these lim-
itations, we have developed a new hybrid method, GPCR-I-
TASSER, which can exploit distant homology templates and1546 Structure 23, 1538–1549, August 4, 2015 ª2015 Elsevier Ltd All rights reservedspatial restraints from low-resolution but
more easy to acquire experimental data
to assist high-resolution GPCR structure
modeling.
In addition to the generic knowledge-
based force field, a set of new GPCR-
and TM-protein-specific energy terms,including membrane repulsion, hydrophobic moment, and
enhanced aromatic and cation-p interactions, were introduced
to guide the GPCR-I-TASSER structure assembly simulations.
Our unpublished data showed that the inclusion of these TM-
specific potentials resulted in a TM-score increase of the
GPCR structure models by 3.5% on the test proteins with a p
value < 105. For the targets that do not have close homologies,
a new ab initio folding procedure was developed to construct the
TM-helix bundles from scratch, which are further refined by the
fragment assembly simulations. This hybrid pipeline enables
the structure construction of different families of GPCRs, which
is essential for genome-wide GPCR modeling and GPCR-ligand
screening. Although progress was made to advance computa-
tional methods for GPCRmodeling, accuracy can still be limited,
especially in the de novo cases and in the loop and tail regions.
We provide local confidence scores to help identify these uncer-
tain regions.
The GPCR-I-TASSER method was tested on two bench-
marks. First, it was tested on 24 GPCR proteins that have an
experimentally solved structure. After excluding all homologous
proteins with a sequence identity > 30% and templates detect-
able by PSI-BLAST, the threading programs successfully iden-
tified templates of correct topology with an average TM-score =
0.675 and RMSD = 5.74 A˚. After the GPCR-I-TASSER struc-
tural reassembly refinement, the TM-score of final models
increased to 0.806 by 19.4% and RMSD reduced to 4.22 A˚
by 1.52 A˚ in the same threading-aligned region (or 2.40 A˚ in
the TM-helix region). Even with the most stringent template
filtering, i.e., excluding all GPCR and TM proteins from the tem-
plate library, the ab initio folding procedure constructed correct
folds for 20 cases with a TM-score > 0.5 (or 22 cases in the TM
regions). These data demonstrate a significant advantage over
the traditional homology-based approaches such as MODEL-
LER (Sali and Blundell, 1993), in which none of the models
can have a TM-score > 0.25 without using the GPCR templates
in our tests.
Second, we tested GPCR-I-TASSER in the community-wide
blind GPCR Dock experiment. The final models of the CXCR4
and D3 receptors have a TM-score 11% and 46% higher than
the threading templates. The RMSD of the TM regions was
2.08, 2.58, and 1.26 A˚, which are 0.98, 0.48, and 0.35 A˚ lower
than the corresponding initial templates, respectively. These
Figure 9. Examples of the First GPCR-I-
TASSER Models in Comparison with Exper-
imental Mutagenesis Data
(A) Formyl peptide receptor; (B) C5a anaphylatoxin
chemotactic receptor; (C) type 1 galanin receptor;
(D) type 1 angiotensin II receptor. Dashed lines
connect the residue pairs supposed to be in con-
tact in the mutagenesis data, which are all within
10 A˚ in the GPCR-I-TASSER models.predictions have a higher average significance score (Z-score)
than the other 34 predictor groups.
We applied theGPCR-I-TASSERpipeline to themodeling of all
1,026 putative GPCR proteins collected from the UniProt and
GPCR-DB databases. There are 923 cases that are expected
to have a correct global fold with a predicted TM-score > 0.5,
based on the correlation between C score and TM score. The
targets with high-confidence models include many unsolved
but pharmaceutically important GPCR families including Trace
amine, Prostanoids, Releasing hormones, Melanocortins, Vaso-
pressin, and Neuropeptide Y receptors. The sequence and
structure-based clustering studies showed that the structures
of GPCRs are more conserved than the sequences during evolu-
tion. As part of cross-validations, we compared the GPCR-I-
TASSER models with experimental mutagenesis data, which
were not used in our structure modeling. Consistency with the
experimental data was demonstrated in all GPCR-I-TASSER
models that have a confidence score above 1.0. These results
demonstrated new progress on genome-wide structure
modeling of GPCRs.Structure 23, 1538–1549, August 4, 2015 ªEXPERIMENTAL PROCEDURES
GPCR-I-TASSER is designed to construct 3D
models of GPCRs and consists of three steps
of TM-helix assembly, full-length structure reas-
sembly simulations, and model selection and
atomic-level structure refinement (Figure 1). The
processes are outlined below, with detailed proce-
dures described in Supplemental Experimental
Procedure.
Generation of Transmembrane Helix
Framework
The query GPCR sequence is threaded through
the PDB by LOMETS (Wu and Zhang, 2007), a
meta-threading approach containing nine cut-
ting-edge threading programs, to identify appro-
priate structure templates. The regions of extra-/
intra-cellular loops and TM helices are predicted
separately and introduced as additional alignment
constraints to enhance the accuracy of the thread-
ing alignments for GPCRs (see Equation S1 in Sup-
plemental Experimental Procedure).
If no significant template is identified, a new ab
initio folding approach is developed to construct
the TM framework by replica-exchange Monte
Carlo (MC) simulation, starting from seven ideal
helices located sequentially along a perimeter of
8 A˚. The MC movements involve translation, rota-
tion, and tilting of the helices, and sequence shifts
along the helix, addition/deletion of residues, and
helix kinking (Figure 3). The simulations are guided
by a simple force field consisting of a knowledge-based, distance-specific contact potential, RW (Random Walk; Zhang and
Zhang, 2010b), and the free energy change of GPCR and water/lipid interac-
tions (Lomize et al., 2006) (see Equations S2 and S3 in Supplemental Experi-
mental Procedure).
Template-Based Fragment Assembly Simulations
Full-length GPCR models were constructed by reassembling the continuous
fragments (mainly TM helices) excised from LOMETS threading alignments
or ab initio TM-helix models, following the I-TASSER protocol (Roy et al.,
2010; Yang et al., 2015). The force field of theGPCR-I-TASSER simulation con-
sists of three components. The first component is a generic knowledge-based
potential extended from I-TASSER that includes statistical Ca and side-chain
contact potentials, backbone-orientation specific hydrogen-bond, solvation
from neural network prediction, and predicted secondary structure propen-
sities; the second is spatial restraints derived from LOMETS templates and/or
ab initio TM-helix models, which consists of Ca distance maps and Ca and
side-chain contacts; and the third component consists of six GPCR- and/or
TM-specific energy terms as described in Equations S4–S10 in Supplemental
Experimental Procedure.
Two types of spatial restraints are derived from the site-directed mutagen-
esis and affinity labeling experiments collected from the GPCR-RD database
(Zhang and Zhang, 2010a). These include contact restraints accounting for
the experimentally identified disulfide bridges and the functionally important2015 Elsevier Ltd All rights reserved 1547
residues (Equation S9), and an orientation restraint of TM-helix to count for the
functionally related point mutations (Equation S10). A general membrane
repulsive potential is introduced in Equation S4 to enhance the GPCR-specific
topology, i.e., all non-TM-helix residues should be excluded from the TM re-
gions (see Figure 5B).
Model Selection and Fragment-Guided Structure Refinement
Structure decoys generated in GPCR-I-TASSER are submitted to SPICKER
(Zhang and Skolnick, 2004c) for structure clustering. The decoys with the high-
est number of structural neighbors are selected, with full-atomic models
refined by the FG-MD simulations (Zhang et al., 2011). Furthermore, the
SPICKER centroid model is used as a probe to identify analog fragments
from the PDB by TM-align (Zhang and Skolnick, 2005), which provides addi-
tional spatial restraints to improve the energy landscape funnel in atomic-level
structure refinements in FG-MD.
Multiple-Domain Assembly
For the GPCRs of multi-domains, we first use ThreaDom (Xue et al., 2013) to
identify the domain boundary and then use GPCR-I-TASSER and I-TASSER
to fold the receptor and globular domains separately. The full-length models
are finally built by docking the domain models using the whole-chain model
as a reference template.
SUPPLEMENTAL INFORMATION
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